Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule I - Condensed Balance Sheet (Details)

v3.25.0.1
Schedule I - Condensed Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
ASSETS        
Total assets $ 1,802,321 $ 1,837,751    
LIABILITIES        
Total liabilities 1,101,861 1,132,287    
STOCKHOLDERS' EQUITY        
Common stock 1,409 1,407    
Preferred stock 0 0    
Additional paid-in capital 1,106,792 1,102,581    
Accumulated deficit (177,508) (170,856)    
Treasury stock, value (222,826) (226,710)    
Accumulated other comprehensive loss (7,407) (958)    
Total equity 700,460 705,464 $ 707,229 $ 740,737
Total liabilities and equity 1,802,321 1,837,751    
Parent Company        
ASSETS        
Investment in subsidiaries 700,460 705,464    
Total assets 700,460 705,464    
LIABILITIES        
Total liabilities 0 0    
STOCKHOLDERS' EQUITY        
Common stock 1,409 1,407    
Preferred stock 0 0    
Additional paid-in capital 1,106,792 1,102,581    
Accumulated deficit (177,508) (170,856)    
Treasury stock, value (222,826) (226,710)    
Accumulated other comprehensive loss (7,407) (958)    
Total equity 700,460 705,464    
Total liabilities and equity $ 700,460 $ 705,464